SEDASYS COMPUTER-ASSISTED PERSONALIZED SEDATION SYSTEM

Computer-assisted Personalized Sedation System

FDA Premarket Approval P080009

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the sedasys® computer-assisted personalized sedation system. This device is indicated for the intravenous administration of 1% (10 mg/ml) propofol injectable emulsion for the initiation andmaintenance of minimal to moderate sedation, as defined by the american society of anesthesiologists (asa) continuum of depth of sedation, in asa physical status i and ii patients >= 18 years old undergoing colonoscopy and esophagogastroduod-denoscopy (egd) procedures.

DeviceSEDASYS COMPUTER-ASSISTED PERSONALIZED SEDATION SYSTEM
Classification NameComputer-assisted Personalized Sedation System
Generic NameComputer-assisted Personalized Sedation System
ApplicantScott Laboratories, Inc
Date Received2008-03-25
Decision Date2013-05-03
Notice Date2013-05-08
PMAP080009
SupplementS
Product CodePDR
Docket Number13M-0549
Advisory CommitteeAnesthesiology
Expedited ReviewYes
Combination Product No
Applicant Address Scott Laboratories, Inc 2804 N. Loop 289 lubbock, TX 79415
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P080009Original Filing
S012
S011 2015-11-18 Real-time Process
S010 2015-10-28 Real-time Process
S009 2015-09-08 Special (immediate Track)
S008 2015-06-16 Special (immediate Track)
S007 2015-04-06 Real-time Process
S006
S005 2015-01-29 Normal 180 Day Track No User Fee
S004
S003 2014-05-28 Normal 180 Day Track No User Fee
S002 2014-05-28 Normal 180 Day Track No User Fee
S001 2013-06-27 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.